Forschner A - Search Results

1

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.

Wölffer M, Battke F, Schulze M, Feldhahn M, Flatz L, Martus P, Forschner A. Wölffer M, et al. Among authors: forschner a. Cancers (Basel). 2022 Jan 8;14(2):302. doi: 10.3390/cancers14020302. Cancers (Basel). 2022. PMID: 35053465 Free PMC article.

2

Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study.

Reinert CP, Liang C, Weissinger M, Vogel J, Forschner A, Nikolaou K, la Fougère C, Seith F. Reinert CP, et al. Among authors: forschner a. Diagnostics (Basel). 2023 Jun 5;13(11):1963. doi: 10.3390/diagnostics13111963. Diagnostics (Basel). 2023. PMID: 37296815 Free PMC article.

3

Impact of ¹⁸F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis.

Forschner A, Olthof SC, Gückel B, Martus P, Vach W, la Fougère C, Nikolaou K, Keim U, Eigentler TK, Garbe C, Pfannenberg C. Forschner A, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1312-1318. doi: 10.1007/s00259-017-3674-8. Epub 2017 Mar 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 28315947 Clinical Trial.

4

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study.

Forschner A, Battke F, Hadaschik D, Schulze M, Weißgraeber S, Han CT, Kopp M, Frick M, Klumpp B, Tietze N, Amaral T, Martus P, Sinnberg T, Eigentler T, Keim U, Garbe C, Döcker D, Biskup S. Forschner A, et al. J Immunother Cancer. 2019 Jul 12;7(1):180. doi: 10.1186/s40425-019-0659-0. J Immunother Cancer. 2019. PMID: 31300034 Free PMC article. Clinical Trial.

5

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma.

Forschner A, Hilke FJ, Bonzheim I, Gschwind A, Demidov G, Amaral T, Ossowski S, Riess O, Schroeder C, Martus P, Klumpp B, Gonzalez-Menendez I, Garbe C, Niessner H, Sinnberg T. Forschner A, et al. Cancers (Basel). 2020 Feb 26;12(3):540. doi: 10.3390/cancers12030540. Cancers (Basel). 2020. PMID: 32110946 Free PMC article.

6

Influence of ¹⁸F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach.

Olthof SC, Forschner A, Martus P, Garbe C, Nikolaou K, la Fougère C, Gückel B, Vach W, Pfannenberg C. Olthof SC, et al. Among authors: forschner a. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2313-2321. doi: 10.1007/s00259-020-04733-x. Epub 2020 Mar 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32123968

7

Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma.

Amaral T, Seeber O, Mersi E, Sanchez S, Thomas I, Meiwes A, Forschner A, Leiter U, Eigentler T, Keim U, Garbe C. Amaral T, et al. Among authors: forschner a. Cancers (Basel). 2020 Apr 22;12(4):1027. doi: 10.3390/cancers12041027. Cancers (Basel). 2020. PMID: 32331243 Free PMC article.

8

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Amaral T, Schulze M, Sinnberg T, Nieser M, Martus P, Battke F, Garbe C, Biskup S, Forschner A. Amaral T, et al. Among authors: forschner a. Cancers (Basel). 2020 Apr 28;12(5):1101. doi: 10.3390/cancers12051101. Cancers (Basel). 2020. PMID: 32354124 Free PMC article.

9

Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study.

Forschner A, Weißgraeber S, Hadaschik D, Schulze M, Kopp M, Kelkenberg S, Sinnberg T, Garbe C, Biskup S, Battke F. Forschner A, et al. Onco Targets Ther. 2020 Jun 4;13:5017-5032. doi: 10.2147/OTT.S248237. eCollection 2020. Onco Targets Ther. 2020. PMID: 32581559 Free PMC article.

10

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients.

Hilke FJ, Sinnberg T, Gschwind A, Niessner H, Demidov G, Amaral T, Ossowski S, Bonzheim I, Röcken M, Riess O, Garbe C, Schroeder C, Forschner A. Hilke FJ, et al. Among authors: forschner a. Cancers (Basel). 2020 Aug 20;12(9):2359. doi: 10.3390/cancers12092359. Cancers (Basel). 2020. PMID: 32825510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page